The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction | Molecular Biology of Disease
The EMBO Journal (2003) 22, 4666–4676, doi:10.1093/emboj/cdg469
Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia
Alfonso Mora1, Anthony M. Davies2, Luc Bertrand3, Isam Sharif4, Grant R. Budas2, Sofija Jovanovic acute2, Véronique Mouton3, C. Ronald Kahn5, John M. Lucocq6, Gillian A. Gray4, Aleksandar Jovanovic acute2 and Dario R. Alessi1
1 MRC Protein Phosphorylation Unit, School of Life Sciences, MSI/WTB Complex, University of Dundee, Dow Street, Dundee DD1 5EH, UK
2 Maternal and Child Health Sciences, Tayside Institute of Child Health, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
3 Hormone and Metabolic Research Unit, Institute of Cellular Pathology and University of Louvain Medical School, Belgium
4 Centre for Cardiovascular Science, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK
5 Joslin Diabetes Centre, Department of Medicine, Harvard Medical School, Boston, MA, USA
6 Division of Cell Biology and Immunology, School of Life Sciences, MSI/WTB Complex, University of Dundee, Dow Street, Dundee DD1 5EH, UK

To whom correspondence should be addressed
Alfonso Mora, a.m.corral@dundee.ac.uk

Received 14 February 2003; Revised 10 July 2003; Accepted 28 July 2003.
Abstract
We employed Cre/loxP technology to generate mPDK1-/- mice, which lack PDK1 in cardiac muscle. Insulin did not activate PKB and S6K, nor did it stimulate 6-phosphofructo-2-kinase and production of fructose 2,6-bisphosphate, in the hearts of mPDK1-/- mice, consistent with PDK1 mediating these processes. All mPDK1-/- mice died suddenly between 5 and 11 weeks of age. The mPDK1-/- animals had thinner ventricular walls, enlarged atria and right ventricles. Moreover, mPDK1-/- muscle mass was markedly reduced due to a reduction in cardiomyocyte volume rather than cardiomyocyte cell number, and markers of heart failure were elevated. These results suggested mPDK1-/- mice died of heart failure, a conclusion supported by echocardiographic analysis. By employing a single-cell assay we found that cardiomyocytes from mPDK1-/- mice are markedly more sensitive to hypoxia. These results establish that the PDK1 signalling network plays an important role in regulating cardiac viability and preventing heart failure. They also suggest that a deficiency of the PDK1 pathway might contribute to development of cardiac disease in humans.
Keywords: cardiac muscle, heart failure, hypoxia, PDK1, PI 3-kinase, PKB, Akt
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2003 by the European Molecular Biology Organization